Journal of Dermatological Treatment

Papers
(The H4-Index of Journal of Dermatological Treatment is 24. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2020-04-01 to 2024-04-01.)
ArticleCitations
Teledermatology: a useful tool to fight COVID-1965
Minoxidil: a comprehensive review54
Real-world practice indirect comparison between guselkumab, risankizumab, and tildrakizumab: results from an Italian 28-week retrospective study53
Inpatient teledermatology during the COVID-19 pandemic41
Guselkumab is efficacious and safe in psoriasis patients who failed anti-IL17: a 52-week real-life study39
Targeted therapies for patients with moderate-to-severe psoriasis: a systematic review and network meta-analysis of PASI response at 1 year38
Biologics for psoriasis patients in the COVID-19 era: more evidence, less fears38
The danger of neglecting melanoma during the COVID-19 pandemic37
Dupilumab in prurigo nodularis: a systematic review of current evidence and analysis of predictive factors to response34
Dermatological consultations in the COVID-19 era: is teledermatology the key to social distancing? An Egyptian experience31
Efficacy, safety, and drug survival of IL-23, IL-17, and TNF-alpha inhibitors for psoriasis treatment: a retrospective study30
Guselkumab in moderate to severe psoriasis in routine clinical care: an Italian 44-week real-life experience30
Melasma treatment: a systematic review30
Short-term stress-related increasing cases of alopecia areata during the COVID-19 pandemic29
‘Loss of efficacy of topical 5% permethrin for treating scabies: an Austrian single-center study’29
Absolute and relative psoriasis area and severity index (PASI) treatment goals and their association with health-related quality of life29
Efficacy of brodalumab in the treatment of scalp and nail psoriasis: results from three phase 3 trials28
The versatility of azelaic acid in dermatology27
Repigmentation in vitiligo using janus kinase (JAK) inhibitors with phototherapy: systematic review and Meta-analysis27
Topical finasteride for the treatment of male androgenetic alopecia and female pattern hair loss: a review of the current literature27
Safety of dupilumab in atopic patients during COVID-19 outbreak25
Comparison of oral minoxidil, finasteride, and dutasteride for treating androgenetic alopecia25
COVID-19 and psoriasis: biologic treatment and challenges25
A challenging case of psoriasis flare-up after COVID-19 infection25
Baricitinib improves symptoms in patients with moderate-to-severe atopic dermatitis and inadequate response to topical corticosteroids: patient-reported outcomes from two randomized monotherapy phase 24
Dupilumab for the treatment of adult atopic dermatitis in special populations24
0.065520048141479